PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
3517475-6	1986	10 and 20 mg BAY o 1248 not only reduced the increases in blood glucose and serum insulin after breakfast, but also after lunch (10 mg).	emiglitate	13-23	insulin	Homo sapiens	82-89
8625892-3	1996	We report here, with a combined in vitro and in vivo approach, that selective inhibition of islet lysosomal glycogenolytic acid glucan-1,4-alpha-glucosidase activity by the long-acting 1-deoxynojirimycin derivative emiglitate induces a profound suppression of nutrient-induced insulin release.	emiglitate	215-225	sucrase isomaltase (alpha-glucosidase)	Mus musculus	139-156
1815967-0	1991	Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers.	emiglitate	122-132	sucrase-isomaltase	Homo sapiens	82-99
3520133-1	1986	BAYo1248 and BAYm1099 are two new alpha-glucosidase inhibitors.	emiglitate	0-8	sucrase-isomaltase	Homo sapiens	34-51
2962844-7	1987	The inhibition of lactase activity was stronger by Bay-m-1099 (Ki = 4.9 X 10(-6) M) than by Bay-o-1248 (Ki = 6.7 X 10(-5) M).	emiglitate	92-102	lactase	Rattus norvegicus	18-25
3100764-0	1987	Chronic effects of an alpha-glucosidase inhibitor (Bay o 1248) on intestinal disaccharidase activity in normal and diabetic mice.	emiglitate	51-61	sucrase isomaltase (alpha-glucosidase)	Mus musculus	22-39